Sort by
Refine Your Search
-
Computational Spatial Biology We are seeking a postdoctoral fellow in computational spatial biology to work in the laboratory of Professor Sylvia Plevritis in the Department of Biomedical Data Science at Stanford
-
2024) in computer science, statistics, a computational social science or related discipline. Demonstrated interest in large language models and study of change. Substantial experience with transformer
-
. Our lab is an inclusive space that fosters learning & curiosity, promotes team work and values mentorship to drive an innovative research program that pushes the boundaries of molecular biology. The
-
for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY25 minimum is $73,800. The Mackall Laboratory is seeking a creative and motivated computational immunologist to join
-
cell biology including neuroscience, GPCRs or related techniques, and/or (3) computational biology are encouraged to apply. We welcome applications from women, minorities, and other underrepresented
-
research program related to the language, literacy, and culture of African Americans. They should have experience with mixed methods research in the humanistic social science tradition. As a portion of the
-
productivity, and the ability to work both independently and collaboratively in a multidisciplinary environment (involving clinicians, computer scientists, and statisticians). A strong background in
-
(SCBE) announces a post-doctoral fellowship position. One postdoctoral fellowship position is available in the Stanford Training Program in Ethical, Legal, and Social Implications (ELSI) Research and at
-
or Chemical Engineering. • Prior work experience in hands-on laboratory experimentation. Prior work in microfabrication, engineering design (computer-aided design), and soft lithography. • Potential experience
-
use of cutting-edge informatics to prioritize causal variants for validation using functional genomics, including CRISPR. The overall goals of this work are to define novel disease targets and context